Outlook Therapeutics, Inc. Common Stock (OTLK)
Since May 14, 2021, Outlook Therapeutics, Inc. Common Stock (OTLK) has reported earnings 21 times. On average the shares move ±5.06% post-earnings, with a positive reaction 52.4% of the time. Its largest post-earnings gain was +17.54% (Dec 27, 2024) and its largest decline was -14.67% (Feb 17, 2026). The next earnings report is predicted for 2026-08-14 (approximate).
Earnings reactions
How OTLK moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±5.06%
Positive %
52.4%
Negative %
47.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 18, 2026 | ☽ POST | -0.39% | open_in_new |
| Feb 17, 2026 | ☀ PRE | -14.67% | open_in_new |
| Dec 19, 2025 | ☀ PRE | -3.6% | open_in_new |
| Aug 14, 2025 | ☽ POST | -3.29% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±5.06%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260723 | open_in_new SEC.gov |
| 4 | 20260723 | open_in_new SEC.gov |
| 424B3 | 20260721 | open_in_new SEC.gov |
| EFFECT | 20260721 | open_in_new SEC.gov |
| S-3 | 20260717 | open_in_new SEC.gov |
| 8-K | 20260716 | open_in_new SEC.gov |
| DEFA14A | 20260710 | open_in_new SEC.gov |
| DRS | 20260708 | open_in_new SEC.gov |
| 8-K | 20260626 | open_in_new SEC.gov |
| 8-K | 20260616 | open_in_new SEC.gov |
Frequently asked about OTLK earnings
When does Outlook Therapeutics, Inc. Common Stock report earnings next? expand_more
Outlook Therapeutics, Inc. Common Stock (OTLK)'s next earnings date is approximate for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does OTLK stock move after earnings? expand_more
Over 21 reports, OTLK has moved an average of ±5.06% the session after earnings, closing higher 52.4% of the time.
What was OTLK's biggest post-earnings move? expand_more
OTLK's largest post-earnings gain on record was +17.54% on Dec 27, 2024, and its largest decline was -14.67% on Feb 17, 2026.
Where can I find Outlook Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Outlook Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right